Montanova Capital LLC Takes $8.74 Million Position in CVS Health Corporation $CVS

Key Points

• Montanova Capital acquired 84,500 CVS Health shares worth approximately $8.74 million during the second quarter. Institutional investors collectively own 80.66% of the company.
• Analyst sentiment remains favorable: 22 analysts rate CVS a Buy and two rate it Hold, resulting in a consensus “Moderate Buy” rating and an average price target of $107.17.
• CVS reported quarterly EPS of $2.58, exceeding estimates of $1.87, while revenue rose 7.3% year over year to $106.10 billion. The company also maintains a quarterly dividend of $0.665 per share, equivalent to a 2.8% annualized yield.

Montanova Capital LLC acquired a new position in shares of CVS Health Corporation (NYSE:CVS - Free Report) in the 2nd quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund acquired 84,500 shares of the pharmacy operator's stock, valued at approximately $8,742,000.

Other hedge funds and other institutional investors have also made changes to their positions in the company. Sigma Planning Corp boosted its stake in shares of CVS Health by 3.6% during the 2nd quarter. Sigma Planning Corp now owns 15,568 shares of the pharmacy operator's stock worth $1,610,000 after purchasing an additional 540 shares during the period. Benjamin Edwards Inc. raised its position in CVS Health by 32.8% in the 2nd quarter. Benjamin Edwards Inc. now owns 45,247 shares of the pharmacy operator's stock worth $4,681,000 after purchasing an additional 11,173 shares during the period. Alyeska Investment Group L.P. bought a new stake in CVS Health in the second quarter worth about $174,359,000. Flputnam Investment Management Co. grew its stake in shares of CVS Health by 4.9% during the second quarter. Flputnam Investment Management Co. now owns 33,778 shares of the pharmacy operator's stock valued at $3,494,000 after buying an additional 1,578 shares during the last quarter. Finally, Wedbush Securities Inc. boosted its holdings in CVS Health by 3.1% during the 2nd quarter. Wedbush Securities Inc. now owns 14,155 shares of the pharmacy operator's stock valued at $1,464,000 after acquiring an additional 427 shares during the period. Hedge funds and other institutional investors own 80.66% of the company's stock.

Wall Street Analyst Weigh In

CVS has been the topic of a number of recent analyst reports. TD Cowen increased their target price on CVS Health from $105.00 to $110.00 and gave the stock a "buy" rating in a research note on Monday, May 11th. Cantor Fitzgerald raised their price target on shares of CVS Health from $100.00 to $110.00 and gave the stock an "overweight" rating in a research note on Tuesday, July 7th. Royal Bank Of Canada lifted their price objective on shares of CVS Health from $107.00 to $113.00 and gave the company an "outperform" rating in a report on Thursday, July 9th. DA Davidson upped their target price on shares of CVS Health from $80.00 to $100.00 and gave the stock a "buy" rating in a research note on Thursday, May 7th. Finally, Argus boosted their price target on CVS Health from $104.00 to $114.00 and gave the company a "buy" rating in a report on Wednesday, August 19th. Twenty-two research analysts have rated the stock with a Buy rating and two have given a Hold rating to the company's stock. Based on data from MarketBeat, CVS Health currently has a consensus rating of "Moderate Buy" and an average price target of $107.17.

CVS Health Trading Up 1.0%

CVS stock opened at $94.02 on Tuesday. CVS Health Corporation has a 52-week low of $69.51 and a 52-week high of $110.68. The company has a quick ratio of 0.66, a current ratio of 0.87 and a debt-to-equity ratio of 0.74. The firm has a market cap of $120.25 billion, a P/E ratio of 24.87, a PEG ratio of 0.91 and a beta of 0.61. The company's 50-day simple moving average is $101.27 and its 200-day simple moving average is $89.68.

CVS Health (NYSE:CVS - Get Free Report) last posted its quarterly earnings data on Wednesday, August 5th. The pharmacy operator reported $2.58 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.87 by $0.71. CVS Health had a return on equity of 13.12% and a net margin of 1.18%.The company had revenue of $106.10 billion for the quarter, compared to analysts' expectations of $100.03 billion. During the same period in the previous year, the firm posted $1.81 EPS. CVS Health's revenue was up 7.3% compared to the same quarter last year. CVS Health has set its FY 2026 guidance at 7.900-8.100 EPS. As a group, equities analysts forecast that CVS Health Corporation will post 8.02 EPS for the current fiscal year.

CVS Health Announces Dividend

The business also recently announced a quarterly dividend, which was paid on Monday, August 3rd. Shareholders of record on Thursday, July 23rd were paid a dividend of $0.665 per share. This represents a $2.66 annualized dividend and a yield of 2.8%. The ex-dividend date of this dividend was Thursday, July 23rd. CVS Health's dividend payout ratio (DPR) is 70.37%.

About CVS Health

CVS Health Corporation is a diversified healthcare company that operates a large network of retail pharmacies, pharmacy benefit management services and health care solutions. Headquartered in Woonsocket, Rhode Island, the company traces its roots to the early 1960s and has grown into an integrated provider of prescription drugs, over‑the‑counter products, clinical services and health insurance offerings. Its operating model combines retail pharmacy locations and in‑store clinics with broader pharmacy and health plan capabilities.

Key business activities include CVS Pharmacy retail operations, MinuteClinic walk‑in medical clinics and HealthHUB locations that offer expanded clinical services.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Add As Preferred Source